Subajini (Suba) Selliah
Compliance & QA/QC Project Manager at Validapro- Claim this Profile
Click to upgrade to our gold package
for the full feature experience.
Topline Score
Bio
Olivier Nicolas
I strongly recommend Suba for a position in any HCV or HIV anti-viral project. She is highly motivated and strongly result oriented. She performed very well in all the aspects of the HCV projetc she was involved in: mutagenesis, cloning, amplification from selected replicon cells, cell culture, RNA transfection.
Tom Chan
I worked with Subajini Selliah (Suba) during my postdoctoral studies at St-Luc Hospital in Montreal, Quebec, Canada under Dr. Marc Bilodeau. Suba was an expert on the topic of Hepatitis C (HCV). Her technical focus was on using polymerase chain reaction to detect viral RNA in HCV-infected hepatocytes and livers. Suba's work culminated in a publication outlining the use of isolated human hepatocytes from HCV-infected livers as a model to study HCV. During our tenure in St. Luc, we also collaborated on an unrelated project concerning a new mechanism of drug interaction. As a result, her work significantly contributed to our recent article showing for the first time an association between drug glucuronidation and vitamin C synthesis in rat hepatocytes. Out of the 3 years that I have worked alongside Suba, I know her be a dependable colleague with a great personality. She has contributed to numerous projects and is devoted to excellence in her work.
Olivier Nicolas
I strongly recommend Suba for a position in any HCV or HIV anti-viral project. She is highly motivated and strongly result oriented. She performed very well in all the aspects of the HCV projetc she was involved in: mutagenesis, cloning, amplification from selected replicon cells, cell culture, RNA transfection.
Tom Chan
I worked with Subajini Selliah (Suba) during my postdoctoral studies at St-Luc Hospital in Montreal, Quebec, Canada under Dr. Marc Bilodeau. Suba was an expert on the topic of Hepatitis C (HCV). Her technical focus was on using polymerase chain reaction to detect viral RNA in HCV-infected hepatocytes and livers. Suba's work culminated in a publication outlining the use of isolated human hepatocytes from HCV-infected livers as a model to study HCV. During our tenure in St. Luc, we also collaborated on an unrelated project concerning a new mechanism of drug interaction. As a result, her work significantly contributed to our recent article showing for the first time an association between drug glucuronidation and vitamin C synthesis in rat hepatocytes. Out of the 3 years that I have worked alongside Suba, I know her be a dependable colleague with a great personality. She has contributed to numerous projects and is devoted to excellence in her work.
Olivier Nicolas
I strongly recommend Suba for a position in any HCV or HIV anti-viral project. She is highly motivated and strongly result oriented. She performed very well in all the aspects of the HCV projetc she was involved in: mutagenesis, cloning, amplification from selected replicon cells, cell culture, RNA transfection.
Tom Chan
I worked with Subajini Selliah (Suba) during my postdoctoral studies at St-Luc Hospital in Montreal, Quebec, Canada under Dr. Marc Bilodeau. Suba was an expert on the topic of Hepatitis C (HCV). Her technical focus was on using polymerase chain reaction to detect viral RNA in HCV-infected hepatocytes and livers. Suba's work culminated in a publication outlining the use of isolated human hepatocytes from HCV-infected livers as a model to study HCV. During our tenure in St. Luc, we also collaborated on an unrelated project concerning a new mechanism of drug interaction. As a result, her work significantly contributed to our recent article showing for the first time an association between drug glucuronidation and vitamin C synthesis in rat hepatocytes. Out of the 3 years that I have worked alongside Suba, I know her be a dependable colleague with a great personality. She has contributed to numerous projects and is devoted to excellence in her work.
Olivier Nicolas
I strongly recommend Suba for a position in any HCV or HIV anti-viral project. She is highly motivated and strongly result oriented. She performed very well in all the aspects of the HCV projetc she was involved in: mutagenesis, cloning, amplification from selected replicon cells, cell culture, RNA transfection.
Tom Chan
I worked with Subajini Selliah (Suba) during my postdoctoral studies at St-Luc Hospital in Montreal, Quebec, Canada under Dr. Marc Bilodeau. Suba was an expert on the topic of Hepatitis C (HCV). Her technical focus was on using polymerase chain reaction to detect viral RNA in HCV-infected hepatocytes and livers. Suba's work culminated in a publication outlining the use of isolated human hepatocytes from HCV-infected livers as a model to study HCV. During our tenure in St. Luc, we also collaborated on an unrelated project concerning a new mechanism of drug interaction. As a result, her work significantly contributed to our recent article showing for the first time an association between drug glucuronidation and vitamin C synthesis in rat hepatocytes. Out of the 3 years that I have worked alongside Suba, I know her be a dependable colleague with a great personality. She has contributed to numerous projects and is devoted to excellence in her work.
Experience
-
Validapro
-
Canada
-
Pharmaceutical Manufacturing
-
1 - 100 Employee
-
Compliance & QA/QC Project Manager
-
Jan 2020 - Present
Consulting firm dedicated to Quality and Compliance in pharmaceutical, medical device and biotechnological industries. Understand the needs of customers and offer required expertise in compliance & QA/QC in Pharmaceutical/Biotech industries: • Remediation plan following an audit or an inventory of fixtures • Preparation of SOPs, reports, batch records, CofA, CC • Validation of analytical methods and equipment • Technology transfers: GAP evaluation of the vaccine recipient site • Preparation of Strategic Compliance Action Plan • Biosafety trainer • Implementation of CCS/CCP, risk analysis and QMS • Project management using the VieGILE project manager • Medical Device regulatory pathway analysis • Preparation of medical device Fact Sheet • IMPD preparation Show less
-
-
-
New World Laboratories
-
Biotechnology Research
-
1 - 100 Employee
-
Head of QC & BSO
-
Jul 2019 - Dec 2019
-
-
QC Research Scientist
-
Jan 2018 - Jul 2019
-
-
-
Centre de recherche du CHUM (CRCHUM)
-
Canada
-
Hospitals and Health Care
-
500 - 600 Employee
-
Research Coordinator-CanHepC Basic Science core
-
Oct 2017 - Jan 2018
http://www.canhepc.ca/en http://www.canhepc.ca/en
-
-
-
Institute of Transformative Bio-Molecules (ITbM), Nagoya University
-
Nagoya, Aichi, Japon
-
Scientific Intern
-
May 2017 - Aug 2017
Pollentube guidance using PDMS microfluidic devices and microscopy in order to study interspecie compatibility and compound screening Pollentube guidance using PDMS microfluidic devices and microscopy in order to study interspecie compatibility and compound screening
-
-
-
Vertex Pharmaceuticals
-
United States
-
Biotechnology Research
-
700 & Above Employee
-
Research Scientist
-
Mar 2009 - Feb 2017
Disease area: Inflammatory Bowl Disease, Kidney diseases & Atopic Dermatitis Disease area: Inflammatory Bowl Disease, Kidney diseases & Atopic Dermatitis
-
-
-
-
Research Associate
-
Mar 2008 - Mar 2009
HIV-1 and HCV related studies HIV-1 and HCV related studies
-
-
-
-
Research Assistant
-
Apr 2005 - Mar 2008
Liver related diseases Liver related diseases
-
-
-
-
Research Assistant/ Co-coordinator of BL-3
-
Jan 2003 - Apr 2005
HIV-1 related studies HIV-1 related studies
-
-
Education
-
2000 - 2002
Université de Montréal
M.Sc., Microbiology/Immunology
Community
